Akoya Biosciences, Inc. (AKYA)
USD 2.45
(-3.54%)
USD 2.45
(-3.54%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | -57.66 Million USD | 15.37% |
| 2022 | -66.2 Million USD | -77.86% |
| 2021 | -37.22 Million USD | -223.92% |
| 2020 | -11.49 Million USD | 14.9% |
| 2019 | -13.5 Million USD | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q2 | -10.99 Million USD | 34.95% |
| 2024 Q1 | -17.03 Million USD | -93.13% |
| 2023 Q4 | -8.82 Million USD | 23.63% |
| 2023 FY | -56.03 Million USD | 15.37% |
| 2023 Q3 | -11.55 Million USD | 39.97% |
| 2023 Q2 | -19.24 Million USD | -11.81% |
| 2023 Q1 | -17.2 Million USD | -0.67% |
| 2022 Q2 | -17.46 Million USD | -13.74% |
| 2022 Q1 | -15.35 Million USD | 8.5% |
| 2022 FY | -66.2 Million USD | -77.86% |
| 2022 Q4 | -17.09 Million USD | -4.9% |
| 2022 Q3 | -16.29 Million USD | 6.69% |
| 2021 Q1 | -5.4 Million USD | -71.51% |
| 2021 FY | -37.22 Million USD | -223.92% |
| 2021 Q4 | -16.78 Million USD | -56.25% |
| 2021 Q3 | -10.73 Million USD | -68.38% |
| 2021 Q2 | -6.37 Million USD | -18.09% |
| 2020 FY | -11.49 Million USD | 14.9% |
| 2020 Q4 | -3.14 Million USD | 14.13% |
| 2020 Q3 | -3.66 Million USD | 4.31% |
| 2020 Q2 | -3.83 Million USD | -181.14% |
| 2020 Q1 | -1.36 Million USD | 0.0% |
| 2019 FY | -13.5 Million USD | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| AngioDynamics, Inc. | -97.71 Million USD | 40.985% |
| AtriCure, Inc. | -26.68 Million USD | -116.123% |
| Avinger, Inc. | -16.63 Million USD | -246.667% |
| Azenta, Inc. | -73.12 Million USD | 21.139% |
| BioLife Solutions, Inc. | -70.82 Million USD | 18.577% |
| The Cooper Companies, Inc. | 533.1 Million USD | 110.817% |
| Daxor Corporation | -177.07 Thousand USD | -32466.991% |
| Ekso Bionics Holdings, Inc. | -15.11 Million USD | -281.604% |
| Femasys Inc. | -14.5 Million USD | -297.48% |
| GlucoTrack, Inc. | -7.1 Million USD | -711.768% |
| Harvard Bioscience, Inc. | 1.89 Million USD | 3144.773% |
| Hologic, Inc. | 882.6 Million USD | 106.534% |
| ICU Medical, Inc. | 22.82 Million USD | 352.653% |
| Intuitive Surgical, Inc. | 1.76 Billion USD | 103.264% |
| KORU Medical Systems, Inc. | -10.26 Million USD | -461.52% |
| LeMaitre Vascular, Inc. | 37.08 Million USD | 255.515% |
| Innovative Eyewear, Inc. | -6.9 Million USD | -735.702% |
| Innovative Eyewear, Inc. | -6.9 Million USD | -735.702% |
| Masimo Corporation | 136.5 Million USD | 142.248% |
| Microbot Medical Inc. | -9.85 Million USD | -485.165% |
| Meihua International Medical Technologies Co., Ltd. | 14.67 Million USD | 492.969% |
| Merit Medical Systems, Inc. | 123.94 Million USD | 146.527% |
| Nephros, Inc. | -1.59 Million USD | -3520.088% |
| NovoCure Limited | -232.87 Million USD | 75.236% |
| NEXGEL, Inc. | -3.47 Million USD | -1558.556% |
| NEXGEL, Inc. | -3.47 Million USD | -1558.556% |
| Singular Genomics Systems, Inc. | -102.8 Million USD | 43.903% |
| OraSure Technologies, Inc. | 54.07 Million USD | 206.637% |
| Pro-Dex, Inc. | 7.17 Million USD | 903.959% |
| Pulse Biosciences, Inc. | -43.57 Million USD | -32.345% |
| Predictive Oncology Inc. | -13.92 Million USD | -314.242% |
| Precision Optics Corporation, Inc. | -2.72 Million USD | -2016.775% |
| QuidelOrtho Corporation | 139.1 Million USD | 141.458% |
| Repligen Corporation | 54.57 Million USD | 205.665% |
| Sanara MedTech Inc. | -4.21 Million USD | -1268.112% |
| STAAR Surgical Company | 28.09 Million USD | 305.246% |
| Sharps Technology, Inc. | -10.12 Million USD | -469.468% |
| Utah Medical Products, Inc. | 16.77 Million USD | 443.732% |
| DENTSPLY SIRONA Inc. | -85 Million USD | 32.155% |
| Jin Medical International Ltd. | 2.86 Million USD | 2111.257% |